- Home
- FTHY vs LAB Comparison
FTHY vs LAB Comparison
Compare FTHY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHY
- LAB
- Stock Information
- Founded
- FTHY 2020
- LAB 1999
- Country
- FTHY United States
- LAB United States
- Employees
- FTHY N/A
- LAB N/A
- Industry
- FTHY Investment Managers
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- FTHY Finance
- LAB Industrials
- Exchange
- FTHY Nasdaq
- LAB Nasdaq
- Market Cap
- FTHY 529.9M
- LAB 562.1M
- IPO Year
- FTHY N/A
- LAB 2011
- Fundamental
- Price
- FTHY $14.55
- LAB $1.88
- Analyst Decision
- FTHY
- LAB Strong Buy
- Analyst Count
- FTHY 0
- LAB 2
- Target Price
- FTHY N/A
- LAB $2.88
- AVG Volume (30 Days)
- FTHY 176.7K
- LAB 1.7M
- Earning Date
- FTHY 01-01-0001
- LAB 02-26-2025
- Dividend Yield
- FTHY 10.93%
- LAB N/A
- EPS Growth
- FTHY N/A
- LAB N/A
- EPS
- FTHY N/A
- LAB N/A
- Revenue
- FTHY N/A
- LAB $155,902,000.00
- Revenue This Year
- FTHY N/A
- LAB $62.60
- Revenue Next Year
- FTHY N/A
- LAB $9.19
- P/E Ratio
- FTHY N/A
- LAB N/A
- Revenue Growth
- FTHY N/A
- LAB 48.23
- 52 Week Low
- FTHY $12.66
- LAB $1.21
- 52 Week High
- FTHY $14.74
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- FTHY 50.34
- LAB 51.01
- Support Level
- FTHY $14.39
- LAB $1.67
- Resistance Level
- FTHY $14.71
- LAB $2.14
- Average True Range (ATR)
- FTHY 0.14
- LAB 0.15
- MACD
- FTHY 0.01
- LAB 0.00
- Stochastic Oscillator
- FTHY 60.95
- LAB 52.73
About FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.